ARTICLE SUMMARY:
With a neuromodulation device targeting the spheno-palatine ganglion, Autonomic Technologies hopes to treat the most difficult kinds of headaches, including cluster headaches and migraines.
When start-ups succeed, it’s almost always due to a mix of expertise: experienced management, top-flight scientific talent, and knowledgeable, patient investors. Autonomic Technologies Inc. (ATI), a company developing a new neuromodulation platform to treat headache pain, has assembled those ingredients.
